LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

ICU Medical Inc

Закрыт

СекторЗдравоохранение

150.69 1.92

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

146.12

Макс.

153.82

Ключевые показатели

By Trading Economics

Доход

-39M

-3.4M

Продажи

-12M

537M

Рентабельность продаж

-0.632

Сотрудники

15,000

EBITDA

-40M

67M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+20.77% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

19 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

544M

3.6B

Предыдущая цена открытия

148.77

Предыдущая цена закрытия

150.69

Новостные настроения

By Acuity

34%

66%

103 / 351 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Very Strong Bullish Evidence

ICU Medical Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

18 февр. 2026 г., 22:31 UTC

Отчет

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 февр. 2026 г., 22:18 UTC

Отчет

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 февр. 2026 г., 22:11 UTC

Отчет

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 февр. 2026 г., 21:52 UTC

Отчет

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 февр. 2026 г., 23:56 UTC

Обсуждения рынка

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

18 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 февр. 2026 г., 23:34 UTC

Обсуждения рынка
Отчет

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 февр. 2026 г., 23:33 UTC

Обсуждения рынка

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 февр. 2026 г., 23:32 UTC

Обсуждения рынка

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 февр. 2026 г., 22:45 UTC

Отчет

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 февр. 2026 г., 22:44 UTC

Обсуждения рынка

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 февр. 2026 г., 22:37 UTC

Отчет

Nutrien 4Q EPS $1.18 >NTR.T

18 февр. 2026 г., 22:37 UTC

Отчет

Nutrien 4Q Sales $5.34B >NTR.T

18 февр. 2026 г., 22:35 UTC

Отчет

Pan American Silver 4Q EPS $1.07 >PAAS

18 февр. 2026 г., 22:35 UTC

Отчет

Pan American Silver 4Q Rev $1.18B >PAAS

18 февр. 2026 г., 22:30 UTC

Отчет

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 февр. 2026 г., 22:29 UTC

Отчет

Kinross Gold 4Q EPS 75c >K.T

18 февр. 2026 г., 22:22 UTC

Отчет

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 февр. 2026 г., 22:22 UTC

Обсуждения рынка

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 февр. 2026 г., 22:16 UTC

Отчет

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 февр. 2026 г., 22:05 UTC

Отчет

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 февр. 2026 г., 22:03 UTC

Отчет

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 февр. 2026 г., 22:02 UTC

Отчет

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 февр. 2026 г., 22:02 UTC

Отчет

Kaiser Aluminum 4Q Sales $929M >KALU

18 февр. 2026 г., 22:02 UTC

Отчет

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 февр. 2026 г., 22:00 UTC

Отчет

Kinross Gold 4Q Adj EPS 67c >KGC

18 февр. 2026 г., 22:00 UTC

Отчет

Kinross Gold 4Q Sales $2.02B >KGC

18 февр. 2026 г., 21:56 UTC

Отчет

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

Сравнение c конкурентами

Изменение цены

ICU Medical Inc Прогноз

Целевая цена

By TipRanks

20.77% рост

Прогноз на 12 месяцев

Средняя 175 USD  20.77%

Максимум 175 USD

Минимум 175 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для ICU Medical Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

1 ratings

1

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

137.16 / N/AПоддержка и Сопротивление

Краткосрочная

Very Strong Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Strong Bearish Evidence

Настроения

By Acuity

103 / 351Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat